IOPAMIRO

This brand name is authorized in Croatia, Estonia, Hong Kong SAR China, Lithuania, Romania, Singapore, Spain, Turkey.

Active ingredients

The drug IOPAMIRO contains one active pharmaceutical ingredient (API):

1	Iopamidol UNII 9679TC07X4 - IODINE
	Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media.
	Read more about Iopamidol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V08AB04	Iopamidol	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
Discover more medicines within V08AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1121342, 1121353, 1121364, 1121375, 1121397, 1121409, 1121410, 1121421, 1130757, 1526138, 1526149
ES	Centro de información online de medicamentos de la AEMPS	57272, 57273
HK	Department of Health Drug Office	23812, 23813
HR	Agencija za lijekove i medicinske proizvode	HR-H-140733276, HR-H-213064000
LT	Valstybinė vaistų kontrolės tarnyba	1011305, 1011306, 1011307, 1011308, 1011309, 1011310, 1011311, 1011312, 1090209, 1090210
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W03756002, W03756003, W03756004, W03757003, W03757004, W03757005, W03757006
SG	Health Sciences Authority	05906P, 05907P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699564772212, 8699564772229, 8699564772236, 8699564772250, 8699564772311, 8699564772328, 8699564772335, 8699564772359